Results 21 to 30 of about 616 (213)

Long-term prophylaxis of hereditary angioedema [PDF]

open access: yesLiječnički vjesnik, 2022
Hereditary angioedema (HAE) is a rare inherited disease characterized by recurrent attacks of painful swelling of the subcutaneous and submucosal tissues.
Dijana Perković   +8 more
doaj   +1 more source

The characteristics of upper airway edema in hereditary and acquired angioedema with C1‐inhibitor deficiency

open access: yesClinical and Translational Allergy, 2021
Background Angioedemas localized in the upper airway are potentially life threatening, and without proper treatment, they may lead to death by suffocation. Upper airway edemas (UAE) in bradykinin‐mediated angioedemas can even be the first symptoms of the
Zsuzsanna Balla   +8 more
doaj   +1 more source

Hereditary Angioedema: Three Cases Report, Members of the Same Family [PDF]

open access: yes, 2010
Background: This current clinical case report highlights three cases of Hereditary angioedema (HAE) patients who are all members of the same family (father and his two daughters).
Alexandros Kolokotronis   +4 more
core   +6 more sources

Clinical Practice Guidelines: Screening, Diagnosis and Management of Acute Events and Prophylaxis of Hereditary Angioedema (HAE) [PDF]

open access: yes, 2021
El AEH es una patología genética, enfermedad rara, con una prevalencia aproximada entre 1 por cada 50,000 habitantes, caracterizado por episodios de edemas a nivel subcutáneo y de mucosas (abdominal, genitourinario, respiratoria), siendo potencialmente ...
Calderón Llosa , Óscar   +6 more
core   +2 more sources

Physician awareness and understanding of hereditary angioedema: A web‐based study in Japan

open access: yesJournal of Cutaneous Immunology and Allergy, 2022
Objectives Hereditary angioedema (HAE) is a rare disease with acute attacks in the skin and mucosa throughout the body including life‐threatening laryngeal edema and abdominal attacks with severe pain.
Atsushi Fukunaga   +6 more
doaj   +1 more source

Recombinant Human C1 Esterase Inhibitor for the Management of Adverse Events Related to Intravenous Immunoglobulin Infusion in Patients With Common Variable Immunodeficiency or Polyneuropathy: A Pilot Open-Label Study

open access: yesFrontiers in Immunology, 2021
It has been hypothesized that low levels of C1 esterase inhibitor (C1-INH), a key inhibitor of the complement pathway, may play a role in the occurrence of adverse events (AEs) associated with intravenous immunoglobulin (IVIG) therapy.
Isaac R. Melamed   +3 more
doaj   +1 more source

Increased thromboinflammatory load in hereditary angioedema [PDF]

open access: yes, 2023
publishedVersio
Gramstad, Olav Rogde   +3 more
core   +2 more sources

Genital ve Karın Bölge Tutulumuyla Giden Çocukluk Çağında Tekrarlayan Anjioödem: C1 İnhibitör İşlevsel Eksikliğine Bağlı Herediter Anjioödem Tip 2 Hastalığı [PDF]

open access: yes, 2020
Hereditary angioedema is a rare disorder characterized by recurrent angioedema attacks due to C1 inhibitor antigen or functional deficiency. Here, two cases with recurrent swelling on extremities, genital organs and face that were later diagnosed with C1
Halime ÇİÇEK, Öner ÖZDEMİR
core   +1 more source

Pathophysiology of Hereditary Angioedema [PDF]

open access: yesPediatric Allergy, Immunology, and Pulmonology, 2014
The genetic deficiency of the C1 inhibitor is responsible for hereditary angioedema (HAE), which is a disease transmitted as an autosomal dominant trait. More than 200 point mutations in the C1 inhibitor gene have been found to be associated with HAE. Patients with this disease suffer from recurrent angioedema, which is mediated by bradykinin derived ...
S. Caccia, C. Suffritti, M. Cicardi
openaire   +2 more sources

Optimum Use of Acute Treatments for Hereditary Angioedema: Evidence-Based Expert Consensus

open access: yesFrontiers in Medicine, 2018
Acute treatment of hereditary angioedema due to C1 inhibitor deficiency has become available in the last 10 years and has greatly improved patients’ quality of life.
Hilary Longhurst
doaj   +1 more source

Home - About - Disclaimer - Privacy